PARAPARA
US • —
$0.00
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
-4.5% YoY
Gross Margin
32.6%
Health Score
3/10
D/E Ratio
0.89
Confidence
LOW
Business Snapshot
This company operates in the media sector, a space that has faced structural headwinds from cord-cutting and ad-market shifts. It holds a position in a consolidating industry, competing for audience share against larger streaming and digital-native platforms. The company's market cap falls in the micro-cap tier, and financial scale is difficult to assess given unavailable revenue data. A defining characteristic is the challenge of managing legacy assets while navigating a transition toward digital distribution, which creates an uncertain operational outlook.
Financial Health
Gross margin sits at 32.6%, though no prior-year comparison is available to gauge trajectory. The net margin is deeply negative at -19.1%, indicating the company is operating at a loss after all expenses...
Risk Assessment
- EARNINGS QUALITY — The company missed earnings estimates in all of the last 4 quarters, indicating poor forecasting credibility.
- REVENUE DECELERATION — Revenue declined 4.5% year-over-year, confirming the top line is shrinking.
- VALUATION — EV/EBITDA of 47.83x is exceptionally high, implying the market is pricing in a turnaround that is not yet evident in the financials.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- PROFITABILITY — Net margin of -19.1% and ROE of -33.2% confirm the company is consistently destroying shareholder equity....
Gross margin sits at 32.6%, though no prior-year comparison is available to gauge trajectory. The net margin is deeply negative at -19.1%, indicating the company is operating at a loss after all expenses. The balance sheet shows a debt/equity ratio of 0.89x and a current ratio of 1.3x, suggesting leverage is manageable but liquidity is not abundant. Negative return on equity of -33.2% highlights that the business is destroying shareholder value, and free cash flow data is unavailable, preventing a full assessment of cash generation. Overall financial health is weak, with persistent losses raising the risk of asset impairment or future dilution.
- EARNINGS QUALITY — The company missed earnings estimates in all of the last 4 quarters, indicating poor forecasting credibility. - REVENUE DECELERATION — Revenue declined 4.5% year-over-year, confirming the top line is shrinking. - VALUATION — EV/EBITDA of 47.83x is exceptionally high, implying the market is pricing in a turnaround that is not yet evident in the financials. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - PROFITABILITY — Net margin of -19.1% and ROE of -33.2% confirm the company is consistently destroying shareholder equity.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives